Development of a high-throughput screening platform for C. difficile toxin synthesis inhibitors unveils meclizine as an antivirulence agent
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.00960-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Ravi K R Marreddy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Clostridioides difficile, High-Throughput Screening Assays, Bacterial Toxins, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Cancer Prevention and Research Institute of Texas, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Clostridioides difficile, a leading cause of hospital-acquired diarrhea, exerts its virulence through two co-regulated toxins, TcdA and TcdB. Despite their pivotal roles, the discovery of inhibitors targeting their biosynthesis is underexplored. Here, we present a high-throughput screening (HTS) platform designed to identify toxin synthesis inhibitors (TSIs) that minimally impact bacterial growth. The primary screen utilized a C. difficile reporter strain expressing secreted Nano-luciferase (secNluc) under the tcdA promoter, whereby inhibition of secNluc production indicates toxin biosynthesis inhibition. Screening the Prestwick Chemical Library at 10 and 100 µM identified several compounds that reduced secNluc activity. Through counter-screening, we eliminated compounds that caused spectral interference. Orthogonal dose-response assays assessing the effectiveness of inhibiting toxin production without affecting growth identified meclizine, an antihistamine, as the primary antivirulence candidate. Meclizine was confirmed as a TSI by showing that it reduced TcdA and TcdB protein levels, the cytopathic potential of cultures, and tcdA and tcdB transcription as determined by ELISA, cell-rounding assays, and RT-qPCR, respectively. Meclizine significantly altered central carbon metabolism in C. difficile , upregulating carbohydrate transport systems and the conversion of lactate to pyruvate, while downregulating glycolytic genes. These changes were associated with intracellular accumulation of glucose and pyruvate, metabolites known to negatively impact toxin production. Taken together, our findings underscore the utility of the above HTS platform to identify anti- C . difficile TSIs, which can serve as molecular and cellular probes, as well as chemical starting points for developing novel therapeutics for C. difficile infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, USA.
- Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, USA.
ORCID-Profile: Abiola O Olaitan, Julian G Hurdle
Förderung
- NIAID NIH HHS
- Cancer Prevention and Research Institute of Texas
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Marreddy, R. K. R., Nguyen, N., Dureja, C., McKelvey, A. M., Powell, R., Olaitan, A. O., Stephan, C., & Hurdle, J. G. (2026). Development of a high-throughput screening platform for C. difficile toxin synthesis inhibitors unveils meclizine as an antivirulence agent. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00960-25
Vancouver
Marreddy RKR, Nguyen N, Dureja C, McKelvey AM, Powell R, Olaitan AO, et al. Development of a high-throughput screening platform for C. difficile toxin synthesis inhibitors unveils meclizine as an antivirulence agent. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00960-25
BibTeX
@article{Marreddy2026,
author = {Marreddy, Ravi K R and Nguyen, Nghi and Dureja, Chetna and McKelvey, Ann Marie and Powell, Reid and Olaitan, Abiola O and Stephan, Clifford and Hurdle, Julian G},
title = {Development of a high-throughput screening platform for C. difficile toxin synthesis inhibitors unveils meclizine as an antivirulence agent},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.00960-25}
}
EUVIMED